Advertisement

Increasing Knowledge of Human Papillomavirus Among Young Adults

      Highlights

      • An educational brochure increased human papillomavirus (HPV) vaccination rates at a primary care office.
      • Clinicians need to use every clinical opportunity to educate about HPV.
      • Barriers still exist with young adults getting vaccinated against HPV.
      • Patient outreach was less effective at increasing HPV vaccine rates.

      Abstract

      HPV is the most common sexually transmitted infection, affecting more than 43 million Americans. HPV is a public health concern because it is the leading cause of cervical, oropharyngeal, vulvar, vaginal, and anal cancer. Despite a highly effective vaccine, the rate of HPV vaccine completion among young adults falls below the Healthy People goal. In efforts to combat this public health concern, an educational brochure was distributed as a quality improvement project in an urban primary care office. After this educational intervention was implemented, there was a significant increase in young adults who received the HPV vaccine from their primary care provider.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal for Nurse Practitioners
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Reference

        • Centers for Disease Control and Prevention
        Human Papillomavirus (HPV): Genital HPV Infection – Fact Sheet.
        https://www.cdc.gov/std/hpv/stdfact-hpv.htm
        Date accessed: February 9, 2021
        • Centers for Disease Control and Prevention
        Human Papillomavirus (HPV): Human Papillomavirus (HPV) Statistics.
        (Retrieved February 9, 2021)
        • McBride E.
        • Tatar O.
        • Rosberger Z.
        • et al.
        Emotional response to testing positive for human papillomavirus at cervical cancer screening: a mixed method systematic review with meta-analysis.
        Health Psychol Rev. 2021; 15: 395-429https://doi.org/10.1080/17437199.2020.1762106
        • Chesson H.W.
        • Ekwueme D.U.
        • Saraiya M.
        • Watson M.
        • Lowy D.R.
        • Markowitz L.E.
        Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States.
        Vaccine. 2012; 30: 6016-6019https://doi.org/10.1016/j.vaccine.2012.07.056
        • Priyadarshini M.
        • Prabhu V.S.
        • Snedecor S.J.
        • et al.
        Economic value of lost productivity attributable to human papillomavirus cancer mortality in the United States.
        Front Public Health. 2021; 8 (Published correction appears in Front Public Health. 2021;9:691634): 624092https://doi.org/10.3389/fpubh.2020.624092
        • Shi L.
        • Sings H.L.
        • Bryan J.T.
        • et al.
        Gardasil: prophylactic human papillomavirus vaccine development—from bench top to bedside.
        Clin Pharmacol Ther. 2007; 81: 259-264https://doi.org/10.1038/sj.clpt.6100055
        • Centers for Disease Control and Prevention
        Human Papillomavirus: HPV Vaccine for Your Child.
        https://www.cdc.gov/hpv/parents/vaccine.html
        Date accessed: February 9, 2021
        • Centers for Disease Control and Prevention
        HPV Vaccine Safety and Effectiveness.
        • Centers for Disease Control and Prevention
        HPV Vaccine Recommendations.
        • Boersma P.
        • Black L.I.
        National Center for Health Statistics: Human Papillomavirus Vaccination Among Adults Aged 18-26, 2013-2018. NCHS Data Brief No. 354, January 2020.
        • Office of Disease Prevention and Health Promotion
        Healthy People 2030: Vaccination. 2020.
        • D’Errico M.P.
        • Tung W.
        • Lu M.
        • D’Errico R.
        Barriers and recommendations associated with human papillomavirus among college students.
        J Nurse Pract. 2020; 16: 533-537https://doi.org/10.1016/j.nurpra.2020.04.011
        • Garcia Jones S.
        • Mathis-Gamble K.
        • Fenkl E.A.
        Minority college students’ HPV knowledge, awareness, and vaccination history.
        J Assoc Nurses AIDS Care. 2017; 28: 675-679https://doi.org/10.1016/j.jana.2017.04.008
        • Johnson C.
        • Ogletree R.
        Knowledge and behavioral intention related to HPV vaccination among male college students.
        Am J Health Educ. 2017; 48: 320-330https://doi.org/10.1080/19325037.2017.1343159
        • McCutcheon T.
        • Schaar G.
        • Herline A.
        • Hayes R.
        HPV awareness and vaccination rates in college-aged male athletes.
        Nurse Pract. 2017; 42: 27-34https://doi.org/10.1097/01.NPR.0000525718.17158.9e
        • Navalpakam A.
        • Dany M.
        • Hajj Hussein I.
        Behavioral perceptions of Oakland University female college students towards human papillomavirus vaccination.
        PLoS One. 2016; 11e0155955https://doi.org/10.1371/journal.pone.0155955
        • Thomas T.L.
        • Dalmida S.G.
        • Threadgill A.I.
        • Ungvary S.
        Beliefs, health habits, and HPV vaccination.
        J Cult Divers. 2019; 26: 138-144https://doi.org/10.1016/j.whi.2012.09.003
        • Vu M.
        • Bednarczyk R.A.
        • Escoffery C.
        • Getachew B.
        • Berg C.J.
        Human papillomavirus vaccination among diverse college students in the state of Georgia: who receives recommendation, who initiates and what are the reasons?.
        Health Educ Res. 2019; 34: 415-434https://doi.org/10.1093/her/cyz014
        • Kester L.M.
        • Shedd-Steele R.B.
        • Dotson-Roberts C.A.
        • Smith J.
        • Zimet G.D.
        The effects of a brief intervention of human papillomavirus knowledge and intention to initiate HPV vaccination in 18-26 year old young adults.
        Gynecol Oncol. 2014; 132: S9-S12https://doi.org/10.1016/j.ygyn0.2013.12.033
        • Lee H.Y.
        • Koopmeiners J.S.
        • McHugh J.
        • Raveis V.H.
        • Ahluwalia J.S.
        mHealth pilot study: text messaging intervention to promote HPV vaccine.
        Am J Health Behav. 2016; 40: 67-76https://doi.org/10.5993/AJHB.40.1.8
        • Molokwu J.
        • Dwivedi A.
        • Mallawaarachchi I.
        • Hernandez A.
        • Shokar N.
        Tiempo de vacunarte (time to get vaccinated): outcomes of an intervention to improve HPV vaccination rates in a predominately Hispanic community.
        Prev Med. 2019; 121: 115-120https://doi.org/10.1016/j.ypmed.2019.02.004
        • Staples J.N.
        • Wong M.S.
        • Rimel B.J.
        An educational intervention to improve human papillomavirus (HPV) and cervical cancer knowledge among African American college students.
        Gynecol Oncol. 2018; 149: 101-105https://doi.org/10.1016/j.ygyn0.2017.10.015
        • Suarez Mora A.
        • Madrigal J.M.
        • Jordan L.
        • Patel A.
        Effectiveness of an educational intervention to increase human papillomavirus knowledge in high-risk minority women.
        J Low Genit Tract Dis. 2018; 22: 288-294https://doi.org/10.1097/LGT.0000000000000386
        • Lanning B.
        • Golman M.
        • Crosslin K.
        Improving human papillomavirus vaccination uptake in college students: a socioecological perspective.
        Am J Health Educ. 2017; 48: 116-128https://doi.org/10.1080/19325037.2016.1271753
        • National Institute of Health
        Cancer Disparities. Updated November 17, 2020.

      Biography

      Carissa Singh, DNP, FNP-C, is a nurse practitioner at University of Rochester Medical Center in Rochester, NY, and can be contacted at [email protected]